Lessons learned from 2 patients with multidrug-resistant HIV-1 infection successfully treated with a darunavir-containing antiretroviral treatment regimen

摘要

The authors describe 2 patients with life-threatening multidrug-resistant HIV-1 infection who responded very well to a treatment regimen containing darunavir and enfuvirtide. They discuss the availability of several new treatment options such as darunavir, etravirine, integrase, and CCR5 inhibitors for patients with multidrug-resistant viruses.